3-iodobenzylguanidine has been researched along with Machado-Joseph Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, M; Hirai, S; Kazuta, T; Yoshita, M | 1 |
Hayashi, M; Hirai, S; Iwasaki, A; Kazuta, T; Nakamura, S; Shimizu, T | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Machado-Joseph Disease
Article | Year |
---|---|
[Iodine-123-labeled meta-iodobenzylguanidine myocardial scintigraphy evaluation of Machado-Joseph disease].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Heart; Humans; Iodine Radioisotopes; Machado-Joseph Disease; Middle Aged; Radionuclide Imaging | 1998 |
Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Female; Heart; Humans; Iodine Radioisotopes; Machado-Joseph Disease; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2000 |